States Push to Combat Opioid Abuse With E-prescribing Technology

April 10, 2017

Opioid medications are prescribed to alleviate pain and suffering, but their abuse and misuse is killing more than 33,000 Americans every year. Prescription painkiller abuse is a problem of epidemic proportions and a significant national public health challenge. The good news is, it’s one that states are increasingly taking action against with an important weapon: health information technology.

Electronic prescribing for controlled substances (EPCS) empowers healthcare providers to play a critical role in decreasing opioid fraud and abuse. When its full capabilities are used, EPCS allows providers to see patients’ medication histories at the point of care, which helps them determine if patients are “doctor shopping” or are exhibiting other behaviors associated with drug abuse. EPCS also ensures prescriptions are securely transmitted from provider to pharmacy without the risk of forgery.

Ultimately, EPCS helps providers proactively minimize opioid drug abuse, which can save lives. That’s why an increasing number of states are following Maine, Minnesota, New York and Virginia in passing legislation that, to varying degrees, mandates the use of EPCS.

The U.S. Drug Enforcement Administration (DEA) approved EPCS in 2010. By 2015, all states had changed their rules to allow EPCS as well. That same year, the number of prescribers using EPCS on the Surescripts network increased by 359%. And in 2016, more than 45 million EPCS transactions crossed our network, which was a 256% increase over 2015. Moreover, prescriber enablement nearly tripled from 5.7% in 2015 to 14.1% in 2016.

In New York State, the I-STOP e-prescribing mandate, which includes an EPCS requirement, took effect in March 2016. Given New York’s increasing enablement levels since the legislation was introduced—73% of the state’s providers are now EPCS-enabled, compared to the national average of 15%—other states can look to New York as proof of how successful EPCS-related legislation can be in driving adoption.

The Virginia Department of Health estimates that 1,000 lives were claimed in the commonwealth during 2016 due to opioid overdoses, an alarming 33% increase over 2015. Virginia’s legislation, which was signed into law on February 23, 2017, requires controlled substances containing opiates to be e-prescribed. It also prohibits pharmacists from dispensing controlled substances containing opiates unless the prescriptions are transmitted electronically.

While EPCS-related mandates have passed in just four states to date, eight others have had similar legislation introduced, including Connecticut, Illinois, Massachusetts, New Jersey, North Carolina, Pennsylvania, Rhode Island, and Texas. See below for detailed information about where each state stands in terms of EPCS legislation.

Looking ahead, we expect to see more states mandate EPCS in some fashion, especially as states like New York show how providers can successfully adopt and use the technology. Given that all of the country’s leading EHRs are now EPCS-enabled, barriers to adoption are lower than ever. Plus, with the myriad of resources available to help guide prescribers through the enablement process step-by-step, saving lives with the help of EPCS has never been easier. In fact, virtually every ambulatory pharmacy in the U.S. is capable of receiving an e-prescription for a controlled substance.

For more information on EPCS and to see where your state ranks in terms of prescriber and pharmacy enablement, click on the maps below. If you are a healthcare provider interested in EPCS, visit To learn how Surescripts, the nation’s leading health information network, is improving patient care and safety with actionable patient intelligence, visit

State EPCS data - 2017 2

*As of April 6, 2017

View the enablement details for your state:

EPCS maps

Related Articles

September 15, 2020

The Opioid Crisis Is Still with Us

Mental health experts and the recovery community have been sounding the alarm for months now. But there are things that the healthcare industry is doing—and can continue to embrace—that are of real help in combatting the crisis. 

July 16, 2020

Revisiting a Groundbreaking Prescribing Regulation

More than a decade ago, the U.S. Drug Enforcement Administration (DEA) published its Electronic Prescribing for Controlled Substances (EPCS) Interim Final Rule (IFR). Surescripts applauded this regulation, which took effect on June 1, 2010. 

March 31, 2020

Five Questions: Ken Whittemore Talks Past, Present & Future of E-Prescribing Controlled Substances

In the early 2000s, as the nation moved towards e-prescribing, Ken Whittemore Jr. was one of the key drivers and proponents of this new technology. By 2007, as a result of the efforts of Surescripts and other stakeholders, e-prescribing had become legal in all 50 states. Three years later, the regulatory climate was ready for the next leap in e-prescribing: in March 2010, the U.S. Drug Enforcement Administration (DEA) issued an Interim Final Rule (IFR) allowing for the electronic prescribing of controlled substances (EPCS) across the nation.  Read more...